妇科合作与授权协议（2016-2025）

"妇科合作与许可协议报告" 以前所未有的方式，全面深入地展现了全球领先的生物製药公司达成的妇科交易。

本报告详细介绍了2016年至2025年间达成的150项妇科交易。

本报告提供了交易双方已公布的付款条款。这些数据有助于深入了解付款条款和其他交易条款。

了解潜在合作伙伴协商条款的弹性，有助于深入了解谈判过程，以便更好地预期谈判结果。虽然许多中小企业会寻求详细的付款条款，但魔鬼藏在细节里，尤其是在付款方式和权利转让方面。

本报告全面列出了自 2016 年以来在 "当前协议" 交易和合作资料库中记录的所有合作与许可协议，并附有财务条款（如有），以及公司及其合作伙伴向美国证券交易委员会提交的实际许可协议文件的在线链接。

本报告第一章探讨了妇科领域的交易和商业活动。第一章为报告的引言，第二章分析了妇科领域的交易趋势。

第三章介绍了妇科领域已达成交易的财务条款及其所处的研发阶段。交易清单按总金额、首付款、里程碑付款和特许权使用费率进行分类。

第四章回顾了妇科领域最活跃的 25 家生物製药公司。对于已公开揭露协议的交易，可透过 "目前协议交易与联盟" 资料库线上存取这些协议。

第五章对自 2016 年以来签署和宣布的妇科交易进行了全面深入的回顾，这些交易的协议文件均可查阅。每个交易标题都透过网路连结指向实际的线上协议文件，方便读者根据需要轻鬆存取每个协议文件。

第六章按目标公司提供了妇科交易的完整目录。

本书也包含大量图表，展示了自 2016 年以来妇科交易的趋势和活动。

此外，本书还提供了一个以公司名称（A-Z）和技术类型组织的综合交易目录。每个交易标题都透过网路连结指向线上交易记录，并包含协议文件（如有），方便读者随时按需存取每个协议文件。

主要优势

妇科合作研究和授权协议为读者提供以下主要优势：

• 了解自 2016 年以来的交易趋势
• 查看妇科合作与许可交易
• 基准分析 - 确定交易市场价值
• 财务条款 - 预付款、里程碑付款、特许权使用费
• 按公司 A-Z、治疗领域和技术类型分类的交易目录
• 主要交易金额
• 最活跃的交易撮合者
• 确定每笔交易的资产和交易条款
• 存取合约文件 - 深入了解交易结构
• 尽职调查 - 评估拟议交易条款是否适合您的合作伙伴
• 节省数百小时的研究时间

范围

• 妇科合作和许可协议报告旨在提供深入的…了解全球领先生物製药公司签署的妇科合作与许可协议的趋势和交易结构。

妇科合作与许可交易包括：

• 生物製药产业妇科交易趋势
• 合作与授权交易结构概述
• 涵盖製药和生物技术的妇科交易记录目录
• 妇科重大交易
• 最活跃的妇科许可交易撮合者

妇科合作与许可交易清单列出了所有可用的交易。

• 公司 A-Z
• 交易金额
• 治疗领域
• 技术类型
• 每个交易标题都透过网路连结连结到实际的线上交易记录，方便查阅合约文件（如有）。
• 妇科合作与许可交易资料库提供全面的交易记录存取权限，包括合约文件。

合约分析有助于对以下方面进行尽职调查：

• 具体授予或选择哪些权利？
• 合约伙伴实际获得哪些权利？
• 授予哪些独家经营权？
• 合约的付款结构是什么？
• 如何进行销售和付款审计？
• 合约期限是多久？
• 如何定义合约的关键条款？
• 如何处理并拥有知识产权？
• 谁负责商业化？
• 谁负责开发、供应和生产？
• 如何管理保密性和资讯揭露？
• 如何解决争议？
• 在什么情况下可以终止合约？
• 如果所有权发生变更，会发生什么事？
• 已达成哪些转许可或分包条款？
• 公司坚持哪些标准条款？
• 哪些格式条款似乎会因合作伙伴和交易类型而异？
• 公司主张适用哪个契约法管辖区？

目录

摘要整理

第一章：引言

第二章：妇科交易趋势

• 引言
• 历年妇科合作状况
• 以交易类型划分的妇科合作
• 按行业划分的妇科合作
• 依研发阶段划分的妇科合作
• 以技术类型划分的妇科合作
• 依治疗适应症划分的妇科合作

第三章 妇科合作的财务条款

• 引言
• 揭露妇科合作的财务条款
• 主要价值妇科合作
• 妇科交易中的预付款
• 妇科交易中的里程碑付款
• 妇科专利费率

第四章 - 妇科关键交易及交易商

• 引言
• 妇科合作中最活跃的交易商
• 最活跃的妇科交易撮合者名单
• 以价格排名的顶级妇科交易

第五章 - 妇科合约文件目录

• 引言
• 提供合约的妇科合作交易

第六章 依治疗标靶划分的妇科交易

• 引言
• 依妇科治疗标靶划分的交易
• 交易目录
• 交易目录 - 妇科交易（按公司、亚利桑那州、2016-2025 年）
• 交易目录 - 妇科交易（依技术类型、2016-2025 年）
• 交易类型定义
• 关于研究公司
• 当前合作伙伴
• 当前协议
• 按目前合作伙伴分类的当前报告标题

Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gynecology deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of 150 gynecology deals from 2016 to 2025.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of gynecology dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in gynecology dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the gynecology field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in gynecology dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of gynecology deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of gynecology deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in gynecology deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Gynecology Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse gynecology collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Gynecology Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of gynecology trends and structure of deals entered into by leading biopharma companies worldwide.

Gynecology Collaboration and Licensing Deals includes:

• Trends in gynecology dealmaking in the biopharma industry
• Overview of collaboration and licensing deal structure
• Directory of gynecology deal records covering pharmaceutical and biotechnology
• The leading gynecology deals by value
• Most active gynecology licensing dealmakers

In Gynecology Collaboration and Licensing Deals, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Gynecology Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking

• 2.1. Introduction
• 2.2. Gynecology partnering over the years
• 2.3. Gynecology partnering by deal type
• 2.4. Gynecology partnering by industry sector
• 2.5. Gynecology partnering by stage of development
• 2.6. Gynecology partnering by technology type
• 2.7. Gynecology partnering by therapeutic indication

Chapter 3 - Financial deal terms for gynecology partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for gynecology partnering
• 3.3. Gynecology partnering headline values
• 3.4. Gynecology deal upfront payments
• 3.5. Gynecology deal milestone payments
• 3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in gynecology partnering
• 4.3. List of most active dealmakers in gynecology
• 4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory

• 5.1. Introduction
• 5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by gynecology therapeutic target
• Deal directory
• Deal directory - Gynecology deals by company A-Z 2016 to 2025
• Deal directory - Gynecology deals by technology type 2016 to 2025
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Gynecology partnering since 2016
• Figure 2: Gynecology partnering by deal type since 2016
• Figure 3: Gynecology partnering by industry sector since 2016
• Figure 4: Gynecology partnering by stage of development since 2016
• Figure 5: Gynecology partnering by technology type since 2016
• Figure 6: Gynecology partnering by indication since 2016
• Figure 7: Gynecology deals with a headline value
• Figure 8: Gynecology deals with upfront payment values
• Figure 9: Gynecology deals with milestone payment
• Figure 10: Gynecology deals with royalty rates
• Figure 11: Active gynecology dealmaking activity since 2016
• Figure 12: Top gynecology deals by value since 2016